T1	Participants 51 88	atrial fibrillation or atrial flutter
T2	Participants 217 316	45 patients with atrial fibrillation or atrial flutter, in a randomized, parallel, open-label study
T3	Participants 318 551	Patients with either new onset (less than 48 hours, n = 31) or old onset (greater than 48 hours, n = 14) of atrial fibrillation or flutter with rapid ventricular rate were stratified to receive esmolol (n = 21) or verapamil (n = 24).
